Dongfang Liu, Ph.D., an Associate Professor (tenured) and Director of the Immunoassay Development Program at the Department of Pathology, Immunology and Laboratory Medicine at Rutgers University- New Jersey Medical School. In 2012, Dr. Liu was recruited to Baylor College of Medicine as a tenure-track Assistant Professor in the Department of Pediatrics, and Pathology & Immunology, before joining Houston Methodist Research Institute (HMRI) as an Assistant Professor in 2015. In 2018, Dr. Liu was promoted to Associate Professor at HMRI. Dr. Liu did his Ph.D. and postdoctoral training on natural killer (NK) cells. After completing the postdoctoral training, he joined the Ragon Institute of MGH, MIT and Harvard in 2011 as a senior research scientist, working on HIV-specific immune cell dysfunction. Dr. Liu’s current research primarily focuses on the immunobiology of NK, immunological synapse and chimeric antigen receptor (CAR)-NK cells. He has more than 20 years of experience in NK cell research. Dr. Liu has published research papers in top-tier journals, including Nature Immunology, Immunity, Nature Communications, JACI, Proc. Natl. Acad. Sci., and others. Dr. Liu serves on several editorial boards for multiple journals and as a reviewer for a number of journals and several grant agencies.
